- Home
- DRUG vs NC Comparison
DRUG vs NC Comparison
Compare DRUG & NC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- NC
- Stock Information
- Founded
- DRUG 2019
- NC 1913
- Country
- DRUG United States
- NC United States
- Employees
- DRUG N/A
- NC N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- NC Coal Mining
- Sector
- DRUG Health Care
- NC Energy
- Exchange
- DRUG Nasdaq
- NC Nasdaq
- Market Cap
- DRUG 233.2M
- NC 247.6M
- IPO Year
- DRUG N/A
- NC N/A
- Fundamental
- Price
- DRUG $25.95
- NC $35.86
- Analyst Decision
- DRUG Strong Buy
- NC
- Analyst Count
- DRUG 6
- NC 0
- Target Price
- DRUG $83.25
- NC N/A
- AVG Volume (30 Days)
- DRUG 29.2K
- NC 8.4K
- Earning Date
- DRUG 05-15-2025
- NC 04-30-2025
- Dividend Yield
- DRUG N/A
- NC 2.82%
- EPS Growth
- DRUG N/A
- NC N/A
- EPS
- DRUG N/A
- NC 4.61
- Revenue
- DRUG N/A
- NC $249,990,000.00
- Revenue This Year
- DRUG N/A
- NC N/A
- Revenue Next Year
- DRUG N/A
- NC N/A
- P/E Ratio
- DRUG N/A
- NC $7.79
- Revenue Growth
- DRUG N/A
- NC 14.71
- 52 Week Low
- DRUG $0.93
- NC $25.19
- 52 Week High
- DRUG $79.02
- NC $39.65
- Technical
- Relative Strength Index (RSI)
- DRUG 30.05
- NC 51.93
- Support Level
- DRUG $26.30
- NC $35.31
- Resistance Level
- DRUG $31.20
- NC $36.70
- Average True Range (ATR)
- DRUG 2.50
- NC 0.99
- MACD
- DRUG -0.55
- NC 0.02
- Stochastic Oscillator
- DRUG 5.59
- NC 52.93
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About NC NACCO Industries Inc.
NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.